Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 5
2007 11
2008 7
2009 7
2010 8
2011 7
2012 7
2013 4
2014 12
2015 6
2016 11
2017 16
2018 22
2019 19
2020 22
2021 28
2022 29
2023 19
2024 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies.
Ramos-Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, De Vita S, Dörner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Retamozo S, Seror R, Shoenfeld Y, Sisó-Almirall A, Tzioufas AG, Vitali C, Bowman S, Mariette X; EULAR-Sjögren Syndrome Task Force Group. Ramos-Casals M, et al. Ann Rheum Dis. 2020 Jan;79(1):3-18. doi: 10.1136/annrheumdis-2019-216114. Epub 2019 Oct 31. Ann Rheum Dis. 2020. PMID: 31672775
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
Punched-out erosions in sacroiliac joints.
Yardımcı GK, Aydıngöz Ü, Kalyoncu U. Yardımcı GK, et al. Among authors: kalyoncu u. Clin Rheumatol. 2021 Sep;40(9):3859-3860. doi: 10.1007/s10067-021-05699-3. Epub 2021 Mar 23. Clin Rheumatol. 2021. PMID: 33755834 No abstract available.
Spondyloarthritides: Theories and beyond.
Kocatürk B, Balık Z, Pişiren G, Kalyoncu U, Özmen F, Özen S. Kocatürk B, et al. Among authors: kalyoncu u. Front Pediatr. 2022 Dec 23;10:1074239. doi: 10.3389/fped.2022.1074239. eCollection 2022. Front Pediatr. 2022. PMID: 36619518 Free PMC article. Review.
Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database.
Ersözlü ED, Ekici M, Coşkun BN, Badak SÖ, Bilgin E, Kalyoncu U, Yağız B, Pehlivan Y, Küçükşahin O, Erden A, Solmaz D, Atagündüz P, Kimyon G, Beş C, Çolak S, Mercan R, Kaşifoğlu T, Emmungil H, Alpay Kanıtez N, Ateş A, Koca SS, Kiraz S, Ertenli İ. Ersözlü ED, et al. Among authors: kalyoncu u. Arch Rheumatol. 2022 Dec 2;38(3):347-357. doi: 10.46497/ArchRheumatol.2023.9504. eCollection 2023 Sep. Arch Rheumatol. 2022. PMID: 38046251 Free PMC article.
The predictors of paradoxical reactions, especially psoriasis, to biologic therapy-findings from the TReasure database: a 5-year follow-up study.
Yagiz B, Lermi N, Coskun BN, Dalkilic E, Kiraz S, Erden A, Ertenli I, Duran E, Bilgin E, Yılmaz R, Ateş A, Tufan A, Küçük H, Mercan R, Cinaklı H, Akar S, Yaşar Bilge NŞ, Kaşifoglu T, Türk SM, Gonullu EO, Bes C, Alpay Kanitez N, Emmungil H, Kalyoncu U, Pehlivan Y. Yagiz B, et al. Among authors: kalyoncu u. Rheumatology (Oxford). 2023 Dec 1;62(12):3962-3967. doi: 10.1093/rheumatology/kead318. Rheumatology (Oxford). 2023. PMID: 37354493
Unmet needs in psoriatic arthritis, a narrative review.
Lopez-Medina C, Kalyoncu U, Gossec L. Lopez-Medina C, et al. Among authors: kalyoncu u. Arch Rheumatol. 2024 May 5;39(2):159-171. doi: 10.46497/ArchRheumatol.2024.10710. eCollection 2024 Jun. Arch Rheumatol. 2024. PMID: 38933724 Free PMC article.
Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates.
Sandal Uzun G, Taghiyeva A, Çakır İY, Moral K, Yardımcı GK, Bölek EÇ, Farisoğulları B, Duran E, Ayan G, Özsoy Z, Ekici M, Unaldı E, Germe ŞA, Fırlatan B, Kart-Bayram GS, Bilgin E, Kılıç L, Karadağ Ö, Akdoğan A, Bilgen ŞA, Kiraz S, Ertenli AI, Kalyoncu U. Sandal Uzun G, et al. Among authors: kalyoncu u. Int J Rheum Dis. 2024 Jan;27(1):e14967. doi: 10.1111/1756-185X.14967. Epub 2023 Dec 6. Int J Rheum Dis. 2024. PMID: 38057290
207 results